Ridhi Gupta

928 total citations
14 papers, 166 citations indexed

About

Ridhi Gupta is a scholar working on Immunology, Hematology and Surgery. According to data from OpenAlex, Ridhi Gupta has authored 14 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Hematology and 2 papers in Surgery. Recurrent topics in Ridhi Gupta's work include Chronic Lymphocytic Leukemia Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). Ridhi Gupta is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). Ridhi Gupta collaborates with scholars based in United States. Ridhi Gupta's co-authors include Byung Moo Lee, Delong Liu, Gurpreet Lamba, Shamudheen Mohammed Rafiyath, Ryan P. Jackson, Beth A. Martin, Yazan Migdady, Sally Arai, Asiri Ediriwickrema and Vandana Sundaram and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Ridhi Gupta

12 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ridhi Gupta United States	6	50	46	43	40	31	14	166
Vikas Ostwal India	9	15 0.3×	58 1.3×	158 3.7×	81 2.0×	7 0.2×	63	273
Nicholas D. Camarda United States	6	13 0.3×	62 1.3×	32 0.7×	83 2.1×	4 0.1×	10	189
Yuriko N. Koyanagi Japan	9	5 0.1×	25 0.5×	88 2.0×	56 1.4×	11 0.4×	18	178
Minami Hashimoto Japan	9	43 0.9×	132 2.9×	111 2.6×	152 3.8×	10 0.3×	59	267
Aydın Çiltaş Türkiye	8	10 0.2×	42 0.9×	41 1.0×	61 1.5×	33 1.1×	18	142
Peter Schuld Germany	7	14 0.3×	13 0.3×	29 0.7×	7 0.2×	138 4.5×	15	201
Satoru Yonekura Japan	9	6 0.1×	56 1.2×	100 2.3×	39 1.0×	8 0.3×	28	282
Takatsugu Ogata Japan	8	20 0.4×	107 2.3×	156 3.6×	57 1.4×	3 0.1×	45	229
Y. Mizushima Japan	5	189 3.8×	298 6.5×	41 1.0×	130 3.3×	29 0.9×	6	383
Marco Filetti Italy	12	26 0.5×	121 2.6×	158 3.7×	57 1.4×	2 0.1×	38	319

Countries citing papers authored by Ridhi Gupta

Since Specialization

Citations

This map shows the geographic impact of Ridhi Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ridhi Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ridhi Gupta more than expected).

Fields of papers citing papers by Ridhi Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ridhi Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ridhi Gupta. The network helps show where Ridhi Gupta may publish in the future.

Co-authorship network of co-authors of Ridhi Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Ridhi Gupta. A scholar is included among the top collaborators of Ridhi Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ridhi Gupta. Ridhi Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pradhan, Kith, Liam Townsend, Mendel Goldfinger, et al.. (2025). Efficacy and manageable toxicity of mogamulizumab in a real-world North American cohort of adult T-cell leukemia/lymphoma (ATLL).. Journal of Clinical Oncology. 43(16_suppl).

Mantzaris, Ioannis, Aditi Shastri, Kira Gritsman, et al.. (2024). Metronomic Low-Dose Regimen of Decitabine and Venetoclax Is Safe and Efficacious for Chronic Myelomonocytic Leukemia. Blood. 144(Supplement 1). 6723–6723.

Migdady, Yazan, Asiri Ediriwickrema, Ryan P. Jackson, et al.. (2020). Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review. Blood Advances. 4(5). 815–818. 28 indexed citations

Mukewar, Saurabh, Ayush Sharma, Ridhi Gupta, et al.. (2018). Risk of Pancreatic Cancer in Patients With Pancreatic Cysts and Family History of Pancreatic Cancer. Clinical Gastroenterology and Hepatology. 16(7). 1123–1130.e1. 16 indexed citations

Cappell, Kathryn M., Vandana Sundaram, Annie Park, et al.. (2018). Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(5). 1035–1040. 21 indexed citations

Migdady, Yazan, et al.. (2018). A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab. Blood. 132(Supplement 1). 4976–4976. 2 indexed citations

Gupta, Ridhi, et al.. (2018). Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD). Blood. 132(Supplement 1). 3409–3409. 2 indexed citations

Quintana, Raymundo A., José Banchs, Ridhi Gupta, et al.. (2017). Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion. Sarcoma. 2017. 1–6. 4 indexed citations

Gupta, Ridhi, et al.. (2016). Fosaprepitant as a risk factor for ifosfamide induced encephalopathy: A single institution experience.. Journal of Clinical Oncology. 34(15_suppl). e14104–e14104. 2 indexed citations

10.

Nabors, Christopher, Sahil Khera, Dhaval Kolte, et al.. (2014). Improving Resident Morning Sign-Out by Use of Daily Events Reports. Journal of Patient Safety. 11(1). 36–41. 2 indexed citations

11.

Furqan, Muhammad, et al.. (2014). The Conundrum of “Warfarin Hypersensitivity”. American Journal of Therapeutics. 23(3). e911–e915. 4 indexed citations

12.

Lamba, Gurpreet, et al.. (2012). Current management and prognostic features for gastrointestinal stromal tumor (GIST). Experimental Hematology and Oncology. 1(1). 14–14. 47 indexed citations

13.

Lamba, Gurpreet, et al.. (2012). Recent advances and novel agents for gastrointestinal stromal tumor (GIST). Journal of Hematology & Oncology. 5(1). 21–21. 28 indexed citations

14.

Wargo, Jennifer A., Alexandria P. Cogdill, Ping Dang, et al.. (2011). Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma. Cancer Research. 71(8_Supplement). 958–958. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact